SCHEMBL24733360

SCHEMBL24733360

Oc1nnc(Cc2ccccc2)c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.56
HTT P42858 3/20 0.56
LMNA P02545 2/20 0.56
PRNP P04156 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
PPARG P37231 1/20 0.56
NCOA2 Q15596 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
SMO Q99835 3/20 0.51
HPGD P15428 1/20 0.50
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CDK1 P06493 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663797 0.87 FLT1 (0.59) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL7663927 0.86 LMNA (0.51) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL7884959 0.86 SMO (0.44) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL7670317 0.83 FLT1 (0.55) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL2310333 0.77 NPSR1 (0.56) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL15077160 0.77 NPSR1 (0.57) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL12050555 0.76 PRMT5 (0.43) NPSR1HTTLMNAPRNPCYP1A2
SCHEMBL350637 0.76 IDO1 (0.47) LMNACYP1A2CYP3A4CYP2C19MEN1
SCHEMBL30082487 0.76 IDO1 (0.47) LMNACYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7664932 0.75 TSHR (0.51) LMNASMOALDH1A1SMN1; SMN2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11413278-B2 Compounds and methods for promoting stress resistance THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11413278-B2 Compounds and methods for promoting stress resistance HSPA9, ATF4, GPX4 NPSR1 2931/4885HTT 2881/4885LMNA 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.